Fred Vaillancourt, — Senior Vice President, Biomolecular Sciences and Lead Discovery at Remix Therapeutics | Comparably
Remix Therapeutics Claimed Company
Remix Therapeutics is developing novel small molecule therapies designed to reprogram RNA processing and treat disease in entirely new ways. Powered by our proprietary REMaster technology platform, we can now create medicines with the unique ability to alter the way genes are read from the genome, correcting dysregulation or eliminating the gene message altogether. These are innovative therapeutic solutions with the potential to address disease drivers at their origin. read more
This company is accepting feedback from verified employees
EMPLOYEE
PARTICIPANTS
35
TOTAL
RATINGS
958
Fred Vaillancourt, — Senior Vice President, Biomolecular Sciences and Lead Discovery at Remix Therapeutics

Fred Vaillancourt, — Senior Vice President, Biomolecular Sciences and Lead Discovery at Remix Therapeutics

Executive Bio

Fred oversees the biomolecular sciences, screening and lead discovery effort at Remix Therapeutics. He joins the team with more than 15 years of experience in a range of roles in drug discovery, most recently serving as a consultant for Third Rock Ventures. Prior to that, Fred held various leadership roles at H3 Biomedicine and Boehringer Ingelheim. Now, Fred is motivated to push the current boundaries of drug discovery with the Remix team. He received his PhD in biochemistry and molecular biology from the University of British Columbia and completed his postdoctoral training as a Merck-sponsored Helen Hay Whitney Foundation fellow at Harvard Medical School.

Executive Team Culture Ratings from Remix Therapeutics Employees

TOP
5%
Remix Therapeutics' Executive Team scores in the Top 5%
of similar sized companies on Comparably
Who ranks the Executive Team the highest?
Experience - Over 10 Years 96/100
Ethnicity - Caucasian 95/100
Gender - Female 95/100
Who ranks the Executive Team the lowest?
Department - Discovery Biology 91/100
Experience - 3 to 6 Years 93/100
Department - Chemistry 94/100

Remix Therapeutics' Executive Team at a Glance

Based on 66 ratings, Remix Therapeutics' employees are very satisfied with their Executive Team and give them an ā€œA+ā€ or 93/100. On average, Women provided higher ratings for their Executive Team compared to Men. Also, the Biomolecular Sciences and Lead Discovery department thinks more highly of the Executive Team relative to the Discovery Biology department.

Remix Therapeutics' Executive Team ranks in the Top 5% of other companies in Boston and Top 5% of other companies on Comparably that also have 51-200 Employees.

×
Rate your company